Trials / Completed
CompletedNCT07333443
Caffeine and Sport Climbing Performance
Caffeine Ingestion at Acute and Moderate Doses Does Not Improve Sport Climbing Performance: Results From a Randomized Controlled Trial.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- University of Alcala · Academic / Other
- Sex
- Male
- Age
- 18 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
To determine the effects of ingesting caffeine at a dose of 3 mg/kg body mass on pull-up performance and handgrip-related measures in trained climbers.
Detailed description
Introduction: Caffeine is widely recognized as a performance-enhancing substance across numerous athletic disciplines; however, its role in sport climbing has received comparatively limited scientific attention. Because climbing performance relies heavily on grip force, explosive upper-body strength, and localized muscular endurance, this investigation evaluated the short-term impact of a low caffeine dose on climbing-relevant performance outcomes. Objective: To determine the effects of ingesting caffeine at a dose of 3 mg/kg body mass on pull-up performance and handgrip-related measures in trained climbers. Methods: Thirteen trained young male climbers participated in a triple-blind, randomized, crossover study design, completing two experimental conditions (caffeine and placebo). Performance assessments included a pull-up one-repetition maximum (1RM), a pull-up power test conducted at multiple external loads, a pull-up endurance test, and several grip performance evaluations, namely maximal dead-hang duration, maximal dead-hang force, and rate of force development (RFD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Acute and moderate dose of caffeine (3 mg/kg body mass) | Caffeine supplementation was provide to young male climbers. |
| DIETARY_SUPPLEMENT | Placebo | Placebo supplementation was provide to young male climbers. |
Timeline
- Start date
- 2025-01-08
- Primary completion
- 2025-03-30
- Completion
- 2025-10-30
- First posted
- 2026-01-12
- Last updated
- 2026-01-12
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT07333443. Inclusion in this directory is not an endorsement.